| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 877,2 k € | +14.5% | 765,9 k € | +4.4% | 733,5 k € | -4.0% | 764,1 k € | +22.2% | 625,2 k € | +12.4% | 556,0 k € | +34.7% | 412,8 k € | +16.1% | 355,6 k € | +13.8% | 312,5 k € | -6.4% | 333,7 k € | +12.2% | 297,3 k € | -0.0% | 297,4 k € | +7.6% | 276,3 k € | +0.3% | 275,5 k € | -10.1% | 306,3 k € | +37.3% | 223,0 k € | +12.1% | 198,9 k € | -5.0% | 209,4 k € | +2.4% | 204,6 k € | |
| EBITDA | 867,8 k € | +14.5% | 757,6 k € | +4.1% | 727,8 k € | -3.8% | 756,2 k € | +22.0% | 620,1 k € | +11.8% | 554,6 k € | +34.6% | 411,9 k € | +16.3% | 354,3 k € | +13.9% | 311,0 k € | -6.4% | 332,3 k € | +13.4% | 293,1 k € | -0.5% | 294,5 k € | +10.0% | 267,7 k € | +0.1% | 267,5 k € | -7.7% | 289,8 k € | +41.3% | 205,1 k € | +11.8% | 183,5 k € | +27.8% | 143,5 k € | -26.7% | 195,7 k € | |
| Operating profit | 843,7 k € | +15.7% | 729,4 k € | +4.3% | 699,3 k € | -4.9% | 735,2 k € | +22.8% | 598,7 k € | +12.3% | 533,2 k € | +36.8% | 389,8 k € | +16.3% | 335,3 k € | +17.7% | 284,8 k € | -6.3% | 304,1 k € | +20.5% | 252,4 k € | +2.1% | 247,3 k € | +18.2% | 209,3 k € | +12.7% | 185,7 k € | -18.5% | 227,9 k € | +64.5% | 138,6 k € | +33.2% | 104,0 k € | +62.6% | 64,0 k € | -48.6% | 124,6 k € | |
| Profit/loss | 617,2 k € | +15.1% | 536,3 k € | +3.0% | 520,8 k € | -8.8% | 570,9 k € | +41.0% | 404,8 k € | +13.2% | 357,7 k € | +43.2% | 249,9 k € | +37.5% | 181,7 k € | +16.6% | 155,9 k € | -10.8% | 174,7 k € | +48.6% | 117,5 k € | -8.0% | 127,7 k € | +31.6% | 97,0 k € | +35.2% | 71,7 k € | -42.8% | 125,4 k € | +80.3% | 69,6 k € | +97.2% | 35,3 k € | +120.0% | 16,0 k € | -70.0% | 53,5 k € | |
| Equity | 3,8 M € | +10.6% | 3,4 M € | +6.1% | 3,2 M € | +19.2% | 2,7 M € | +26.6% | 2,1 M € | +23.3% | 1,7 M € | +25.9% | 1,4 M € | +22.0% | 1,1 M € | +19.1% | 951,9 k € | +19.6% | 796,0 k € | +28.1% | 621,3 k € | +23.3% | 503,8 k € | +34.0% | 376,1 k € | +21.7% | 309,1 k € | -25.4% | 414,0 k € | +43.5% | 288,6 k € | +18.8% | 243,0 k € | +17.0% | 207,7 k € | +8.4% | 191,7 k € | |
| Total assets | 4,6 M € | +9.6% | 4,2 M € | +3.5% | 4,1 M € | +16.6% | 3,5 M € | +20.9% | 2,9 M € | +16.3% | 2,5 M € | +17.9% | 2,1 M € | +16.3% | 1,8 M € | +8.4% | 1,7 M € | +2.0% | 1,6 M € | -2.1% | 1,7 M € | -1.5% | 1,7 M € | -2.0% | 1,7 M € | -9.4% | 1,9 M € | +18.9% | 1,6 M € | +18.1% | 1,4 M € | +2.9% | 1,3 M € | -7.3% | 1,4 M € | +15.3% | 1,2 M € | |
| Cash | 17,9 k € | -2.8% | 18,4 k € | -85.1% | 123,8 k € | +40.1% | 88,3 k € | +80.9% | 48,8 k € | -58.4% | 117,5 k € | +62.4% | 72,4 k € | +965.5% | 6,8 k € | -78.1% | 31,1 k € | +801.7% | 3,4 k € | -45.9% | 6,4 k € | +392.6% | 1,3 k € | -20.7% | 1,6 k € | -31.5% | 2,4 k € | -95.8% | 57,2 k € | +4357.1% | 1,3 k € | -58.3% | 3,1 k € | -97.1% | 107,1 k € | +292.7% | 27,3 k € | |
| Debts | 637,7 k € | +6.6% | 598,3 k € | -8.8% | 655,7 k € | +10.9% | 591,0 k € | +4.2% | 567,4 k € | +0.6% | 564,0 k € | +3.2% | 546,7 k € | +9.6% | 498,8 k € | -7.9% | 541,5 k € | -17.0% | 652,5 k € | -23.9% | 857,3 k € | -14.4% | 1,0 M € | -12.8% | 1,1 M € | -18.0% | 1,4 M € | +38.0% | 1,0 M € | +11.7% | 908,0 k € | -2.1% | 927,1 k € | -14.2% | 1,1 M € | +11.1% | 972,2 k € | |
| Staff | — | — | — | — | — | — | — | — | — | — | — | — | 0,3 | 0,4 | — | — | — | — | — | |||||||||||||||||||
Private limited company · Lebbeke · incorporated on 02/12/1998
Private limited company profitable and well capitalised.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DIRK STEEMANS is a Private limited company incorporated in 1998. Its main activity is: Specialist medical practice activities. Its registered office is in Lebbeke.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette